| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.082 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |